Carregant...
Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by platelet count less than 100×10(9)/L and an increased risk of bleeding. The risk of bleeding increases in proportion with the degree of thrombocytopenia. Although several medications are used for primary thrombocytopenia treatm...
Guardat en:
| Publicat a: | Cureus |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cureus
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7505620/ https://ncbi.nlm.nih.gov/pubmed/32968581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.9920 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|